semaglutide weight loss clinic in massachusetts Norwell & Burlington SEMAGLUTIDE - Concierge Medical Services

Semaglutide base, the active ingredient, can alter hormone levels, so patients with thyroid disorders need to be closely monitored by their doctor during treatment

However, additional research is needed on this possible association

Thats a good question, and the answer is probably different for each person

Published in the New England Journal of Medicine, the trial tested retatrutide at doses of 1mg, 4mg, 8mg, and 12mg against placebo over 48 weeks

The quick answer: Semaglutide is a GLP-1 receptor agonist an injectable (and now oral) drug FDA-approved for long-term, chronic weight management , producing the larger weight loss but at meaningfully higher cost